Puberty is an expected part of development that causes many changes in the body. During this time, children mature and develop into adults. It’s common to experience a few bumps in the road during ...
The FDA has approved Fensolvi (leuprolide acetate; Tolmar Pharmaceuticals) for the treatment of pediatric patients 2 years of age and older with central precocious puberty. The Food and Drug ...
Precocious puberty is puberty that begins earlier than usual. An underlying condition may cause it, but other people experience early puberty for no apparent reason. Even when puberty occurs early ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A higher percentage of girls were diagnosed with rapidly ...
Please provide your email address to receive an email when new articles are posted on . Children with a high genetic risk score and high intake of some sweeteners were more likely to develop central ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Kids who are exclusively breast-fed as infants are less likely to ...
Puberty is the period during which a child develops and changes physiologically and psychologically into an adult. The timing of puberty is defined by complex interactions between environmental, ...
Researchers have identified that a genetic mutation leads to a type of premature puberty, known as central precocious puberty. Reaching puberty at an unusually early age can have adverse effects on ...
Triptodur, a gonadotropin-releasing hormone (GnRH) agonist, is given as an intramuscular (IM) injection every 6 months. Arbor and Debiopharm announced the launch of Triptodur (triptorelin ...
In a new joint study, scientists from Queen Mary University of London have made a breakthrough in understanding the genetic causes of central precocious puberty. Their findings, published in The ...
About three-quarters of cases of central precocious puberty (CPP) in boys have no identifiable cause, say researchers. Ayfer Alikasifoglu (Hacettepe University, Ankara, Turkey) and colleagues assessed ...
Gonadotropin-releasing hormone analogues (GnRHa) can improve adult height prospects in children with central precocious puberty (CPP). A recent report demonstrates that 50 mg histrelin subcutaneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results